The Biotech Forum – Medium

The Biotech Forum

The Biotech Forum

3 Investment Themes Emerging Early In 2017

Jan. 9, 2017 11:54 AM ET

Jan 9, 2017

3 Investment Themes Emerging Early In 2017

Jan 9, 2017

The Biotech Forum

3 Comeback Stories For 2017

Jan. 2, 2017 10:13 AM ET|Includes:Allergan plc (AGN), MYL, SIG, TEVA

Jan 2, 2017

Jan 2, 2017

The Biotech Forum

Christmas Comes Early For These 3 Small Biotech Stocks

“I like coffee because it gives me the illusion that I might be awake.” — Lewis Black

Dec 24, 2016

Christmas Comes Early For These 3 Small Biotech Stocks

Dec 24, 2016

The Biotech Forum

Omeros Corporation: Why This $11 Biotech Has Substantial Upside — Bret Jensen

It is nice to see a large rally today on confidence that the polls are correct and the U.K. does indeed vote to stay in the European Union…

Jun 25, 2016

Omeros Corporation: Why This $11 Biotech Has Substantial Upside — Bret Jensen

Jun 25, 2016

The Biotech Forum

Possible Takeout Targets in Biotech Land — Bret Jensen

Jun 14, 2016 8:20 AM | about stocks: IBB

Jun 14, 2016

Possible Takeout Targets in Biotech Land — Bret Jensen

Jun 14, 2016

The Biotech Forum

The Investment Case On Relypsa Gets Much Stronger. A Buyout Ahead? — Bret Jensen

Originally Published: May 29, 2016

Jun 1, 2016

The Investment Case On Relypsa Gets Much Stronger. A Buyout Ahead? — Bret Jensen

Jun 1, 2016

The Biotech Forum

Brutal Sentiment On Biotech Is Unwarranted — Bret Jensen

Note: For free weekly 7–10 page reports on small attractive biotech stocks, please just register at bretjenseninvests.com. Our last report…

May 20, 2016

Brutal Sentiment On Biotech Is Unwarranted — Bret Jensen

May 20, 2016

The Biotech Forum
in
Keeping Stock

4 Good Bets For Value & Yield In Biotech & Pharma — Bret Jensen

Note: A seven page investment report on a unique and attractively priced ~$6 biopharma stock will be sent free to my registered subscribers…

May 20, 2016

4 Good Bets For Value & Yield In Biotech & Pharma — Bret Jensen

May 20, 2016

The Biotech Forum

Market Outlook: Landmines To Avoid — Bret Jensen

Note: A 10 page report covering two small biotechs under $7.00 a share that are undervalued and could be possible takeout targets as well…

Apr 27, 2016

Market Outlook: Landmines To Avoid — Bret Jensen

Apr 27, 2016

The Biotech Forum
in
Keeping Stock

3 Attractive Biotech Stocks Insiders Are Buying — Bret Jensen

Mark Your Calendars: Our recent Tax Day free two week trial offer expanded our Biotech Forum Community by 30%. Several followers have…

Apr 26, 2016

3 Attractive Biotech Stocks Insiders Are Buying — Bret Jensen

Apr 26, 2016

The Biotech Forum

The Biotech Forum

Compelling biotech research; 20 stock portfolio. We are the #2 investment service @seekingalpha managed by top-ranked analyst @bret_jensen.

Following

See all (1,062)

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams